Cereblon is a direct protein target for immunomodulatory and antiproliferative activities of lenalidomide and pomalidomide

606 indexed citations

Abstract

loading...

About

This paper, published in 2012, received 606 indexed citations. Written by Antonia Lopez‐Girona, Derek Mendy, Takumi Ito, Karl N. Miller, Anita K. Gandhi, Jian Kang, Satoki Karasawa, Gilles Carmel, Pilgrim J. Jackson and Mahan Abbasian covering the research area of Molecular Biology and Hematology. It is primarily cited by scholars working on Molecular Biology (487 citations), Hematology (360 citations) and Oncology (225 citations). Published in Leukemia.

Countries where authors are citing Cereblon is a direct protein target for immunomodulatory and antiproliferative activities of lenalidomide and pomalidomide

Specialization
Citations

This map shows the geographic impact of Cereblon is a direct protein target for immunomodulatory and antiproliferative activities of lenalidomide and pomalidomide. It shows the number of citations coming from papers published by authors working in each country. You can also color the map by specialization and compare the number of citations received by Cereblon is a direct protein target for immunomodulatory and antiproliferative activities of lenalidomide and pomalidomide with the expected number of citations based on a country's size and research output (numbers larger than one mean the country cites Cereblon is a direct protein target for immunomodulatory and antiproliferative activities of lenalidomide and pomalidomide more than expected).

Fields of papers citing Cereblon is a direct protein target for immunomodulatory and antiproliferative activities of lenalidomide and pomalidomide

Specialization
Physical SciencesHealth SciencesLife SciencesSocial Sciences

This network shows the impact of Cereblon is a direct protein target for immunomodulatory and antiproliferative activities of lenalidomide and pomalidomide. Nodes represent research fields, and links connect fields that are likely to share authors. Colored nodes show fields that tend to cite the Cereblon is a direct protein target for immunomodulatory and antiproliferative activities of lenalidomide and pomalidomide.

Rankless uses publication and citation data sourced from OpenAlex, an open and comprehensive bibliographic database. While OpenAlex provides broad and valuable coverage of the global research landscape, it—like all bibliographic datasets—has inherent limitations. These include incomplete records, variations in author disambiguation, differences in journal indexing, and delays in data updates. As a result, some metrics and network relationships displayed in Rankless may not fully capture the entirety of a scholar's output or impact.

This paper is also available at doi.org/10.1038/leu.2012.119.

Explore hit-papers with similar magnitude of impact

Rankless by CCL
2026